Senseonics Holdings, Inc.
NASDAQ:SENSMedical - Devices
Healthcare
$8.91 -1.27%
-$0.09 today
- Market cap
- $487.82M
- Beta
- 0.97
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$1.90
52W Low $4.79High $12.58
Volume 1.32M
Average 0.71M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$59.13M
FY 2025 · Annual
Investing Cash Flow
-$53.42M
FY 2025 · Annual
Financing Cash Flow
$78.19M
FY 2025 · Annual
+191.4% YoYCash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (302.47M) | 142.12M | (60.39M) | (78.62M) | (69.11M) |
| Depreciation & Amortization | 1.24M | 985K | 1.28M | 1.48M | 91K |
| Deferred Income Tax | 229.17M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 9.03M | 8.62M | 8.67M | 9.23M | 10.15M |
| Change in Working Capital | (1.5M) | (2.47M) | (3.97M) | 865K | (3.28M) |
| Accounts Receivables | 1.01M | (478K) | (2.19M) | (2.7M) | (6.77M) |
| Inventory | (1.04M) | (989K) | (1.64M) | 696K | (2.98M) |
| Accounts Payables | (559K) | (785K) | 2.3M | (1.83M) | 1.22M |
| Other Working Capital | (922K) | (219K) | (2.43M) | 4.7M | 5.24M |
| Other Non-Cash Items | 8.46M | (215.56M) | (15.76M) | 6.59M | 3.02M |
| Operating Cash Flow | (56.08M) | (66.31M) | (70.16M) | (60.47M) | (59.13M) |
| Capital Expenditures | (210K) | (312K) | (350K) | (2.24M) | (1.12M) |
| Acquisitions (Net) | 210K | (27.19M) | 0 | 0 | 0 |
| Purchases of Investments | (154.51M) | (104.71M) | (68.54M) | (58.02M) | (100.69M) |
| Sales of Investments | 5.98M | 131.9M | 158.6M | 93.1M | 48.39M |
| Other Investing Activities | (210K) | 27.19M | 0 | 0 | 0 |
| Investing Cash Flow | (148.75M) | 26.88M | 89.71M | 32.84M | (53.42M) |
| Debt Repayment | (2.84M) | (2.93M) | 1.25M | 9.95M | (20.4M) |
| Common Stock Issued | 200.37M | 34.17M | 7.38M | 18.36M | 100.73M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (227K) | (1.49M) | 11.74M | (1.48M) | (2.15M) |
| Financing Cash Flow | 220.08M | 41.76M | 20.37M | 26.83M | 78.19M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 15.26M | 2.33M | 39.92M | (797K) | (34.36M) |
| Free Cash Flow | (56.29M) | (66.62M) | (70.51M) | (62.7M) | (60.25M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$69.1M
+ D&A$91.0K
+ Stock-Based Comp$10.2M
+ Deferred Tax$0
- Working Capital-$3.3M
+ Other Non-Cash$3.0M
= Operating Cash Flow-$59.1M
- Capex-$1.1M
= Free Cash Flow-$60.2M
Analysis
FY2025 free cash flow is -$60.2M. FCF conversion is 87.2% of net income. Operating cash flow was -$59.1M, with capex of -$1.1M. The largest bridge item is Stock-Based Comp at $10.2M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 27, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 5, 2026 |
Does SENS generate free cash flow?
Senseonics Holdings, Inc. (SENS) generated -$60.24M of free cash flow in fiscal 2025.
How much operating cash flow does SENS produce?
Operating cash flow was -$59.13M, before capital expenditures of $1.12M.
Continue the stock analysis
Jump to another research area for this company.